Centrum Medyczne Sheba
Acute lymphoblastic leukemia treatment cost in Israel typically involves a comprehensive diagnosis of leukemia ranging from $3,200 to $5,500. Primary treatments like bone marrow transplantation run from $135,000 to $240,000, while an allogenic bone marrow transplantation from an unrelated donor costs $135,000 to $211,500. Total expenses depend on the clinical stage and protocol complexity, offering 30-80% savings compared to the US. Leading care is concentrated in Tel Aviv, Jerusalem, and Haifa.
Typical Acute Lymphoblastic Leukemia Treatment Costs in Israel
Bookimed Expert Insight: Pediatric patients achieve superior outcomes at specialized centers like Schneider Children's Medical Center. For complex adult cases, Sourasky Medical Center offers a 90% oncology success rate with JCI-accredited standards. Patients requiring advanced cellular therapies should consider Hadassah Medical Center. There, Professor Polina Stepensky has performed over 3,500 bone marrow transplants, specializing in rare blood cancers and innovative gene therapies.
| Izrael | Turcja | Austria | |
| Przeszczepienie szpiku kostnego allogeniczne od dawcy spokrewnionego | od $142,000 | od $65,000 | od $150,000 |
| Przeszczep szpiku kostnego | od $135,000 | od $36,000 | od $140,000 |
| Chemioterapia w raku piersi | od $22,500 | od $1,200 | od $15,000 |
| Autologiczny przeszczep szpiku kostnego | od $58,000 | od $31,500 | od $50,000 |
| Allogeniczna transplantacja szpiku kostnego od niespokrewnionego dawcy | od $135,000 | od $80,000 | od $180,000 |
Dr Ram Ron pracuje w jednym z wiodących i największych publicznych szpitali klinicznych w Izraelu — Centrum Medycznym Sourasky (Ichilov). Placówka ta słynie z wysokiego poziomu opieki nad pacjentem oraz innowacji medycznych.
Dr Ron Ram przeprowadził kilkaset przeszczepów komórek macierzystych, co jest kluczową procedurą w leczeniu ostrej białaczki limfoblastycznej. Jest on certyfikowanym lekarzem hematologiem-onkologiem.
Dr Ronit El Hasid przeprowadziła ponad 300 przeszczepów szpiku kostnego i krwi pępowinowej u dzieci w Szpitalu Dziecięcym im. Dana Dwek.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.